NCT05655195View on ClinicalTrials.gov

Chronic Treatment of Alzheimer's Disease by Gamma Light and Sound Therapy

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 14, 2022

Primary Completion Date

December 1, 2025

Study Completion Date

September 1, 2026

Conditions
Alzheimer DiseaseAlzheimer Disease, Early OnsetAlzheimer Disease, Late OnsetAlzheimer's Disease (Incl Subtypes)Alzheimer'sAlzheimer's Disease
Interventions
DEVICE

GENUS device (Active Settings)

Participants in the active, experimental group will use the GENUS devices configured to active (40Hz) setting for 60 minutes daily for 6 months.

DEVICE

GENUS device (sham settings)

Participants in the control group will use the GENUS devices configured to the sham settings for 60 minutes daily for 6 months.

Trial Locations (1)

02142

RECRUITING

Massachusetts Institute of Technology, Cambridge

All Listed Sponsors
lead

Massachusetts Institute of Technology

OTHER